Is NEO Worth Buying in 2026?

NeoGenomics, Inc.

STOCK SERVICES-TESTING LABORATORIES Updated 2026-04-19

Here’s whether NeoGenomics, Inc. (NEO) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bearish.

🔴
Bearish

Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-8.69% over 10 days); weak 1-year return of -12.7%; 3-month momentum negative (-34.7%); rising volume on a downtrend (distribution, 1.30x avg). Currently 39.2% off its 52-week high. Score: -6/7.

Ready to act on this? 📈 Trade on Webull

NEO is trading below its 200-day MA ($9.35) — a key warning sign the longer-term trend is under pressure. An RSI of 67.8 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of -12.7% compares to +35.1% for SPY (trailed the market by 47.8%). The current 39.2% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $8,734 today
vs. S&P 500 (SPY) — same period trailed market by 47.8%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

Above 200-day MA ($9.35)
Above 50-day MA ($9.00)
RSI(14) neutral zone (30–70) — currently 67.8
Positive return (-12.7%)
!Within 10% of period high (−39.2%)
Period Range $8.35
$4.72 $13.74
RSI (14) 67.8
0 · OversoldOverbought · 100

Key Metrics

Price$8.35
Period Return-12.7%
Period High$13.74
Period Low$4.72
Drawdown−39.2%
MA-50$9.00
MA-200$9.35
RSI (14)67.8
Avg Volume (30d)1.8M
vs. SPYtrailed by 47.8%
Return Rank#778 of 996

Trade NEO

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers